Article info

Download PDFPDF

Original research
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

Authors

  1. Correspondence to Dr Shintaro Iwama; siwama{at}med.nagoya-u.ac.jp; Dr Hiroshi Arima; arima105{at}med.nagoya-u.ac.jp
View Full Text

Citation

Kobayashi T, Iwama S, Yasuda Y, et al
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

Publication history

  • Accepted May 26, 2020
  • First published June 30, 2020.
Online issue publication 
June 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.